Monkeys respond well to Ebola vaccine in study

05/24/2010 | HealthDay News

A vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases appeared to protect cynomolgus macaque monkeys from three strains of the Ebola virus. "This finding will guide future vaccine design and may open an avenue for developing a single vaccine that works against both known and emerging Ebola virus species," said Anthony Fauci, director of the institute.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX